Sartorius to Acquire TAP Biosystems

Deal, which values TAP Biosystems at around $44.8 million, would expand Sartorius' portfolio of single-use fermentors.
Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells. In this image

Designer Multipass Transmembrane Proteins the Latest Cellwear

Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells

LGLS Licenses Novavax’ VLP Technology to Develop Flu Vaccines for South Korea and Other...

Firm will build VLP vaccine manufacturing plant and will also develop flu vaccines for other emerging markets.

Five Life Sciences Researchers Win Breakthrough Prizes Totaling $15M

Five life sciences researchers have been honored as winners of the 2018 Breakthrough Prize in Life Sciences, which honors “transformative” advances toward understanding living systems and extending human life.
GE Healthcare's "factory-in-a-box.

Factory in a Box Launched for Production of Viral Vector–Based Therapeutics

Factory in a box products include vaccines, oncolytic viruses, and gene and cell therapies.

Lonza to Leverage IDBS’ Data Management and Execution Solution

Bioprocess Execution System will will allow storing of data in context and more efficient sharing between groups.

Telesta Cutting Jobs, Selling Manufacturing Sites as MCNA Hopes Fade

After Type A meeting with FDA, company ends rights agreement with Ipsen, concludes no partners "in any region of the world" can be found for MCNA short-term

Human Protein Engineered to Capture Circulating Tumor Cells

Human blood protein that was engineered to capture CTCs may be used as a cancer diagnostic.
Source: Sartorius Stedim Biotech

Sartorius Inks Automation Cooperation Agreement with Siemens

Sartorius Stedim Biotech and Siemens agree to a long-term cooperation agreement in the area of automation

GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal

Firms aim to develop GenVec’s gene-based therapy for restoring hearing and balance.

Recently Featured

Scroll Up